Which are the symptoms of Simpson-Golabi-Behmel syndrome?

TL;DR: Simpson-Golabi-Behmel syndrome (SGBS) is a rare X-linked overgrowth disorder characterized by distinctive facial features, macrocephaly, macrosomia (large body size), and an increased risk of specific childhood tumors. Symptoms vary significantly in severity, often requiring a multidisciplinary clinical approach to manage the diverse physical and developmental needs of affected individuals.

What are the primary clinical features of Simpson-Golabi-Behmel syndrome?

Simpson-Golabi-Behmel syndrome is primarily recognized by a pattern of prenatal and postnatal overgrowth. Individuals often present with a coarse facial appearance, which may include a broad nasal bridge, upturned nose, macrostomia (large mouth), and macroglossia (enlarged tongue). Beyond physical stature, Simpson-Golabi-Behmel syndrome is associated with skeletal abnormalities, such as polydactyly (extra fingers or toes) and vertebral anomalies. Internal organ involvement is common, including visceromegaly (enlarged organs) and renal structural differences. At DiseaseMaps.org, 26 members have shared their experiences, highlighting the heterogeneity of how these symptoms manifest in daily life.

What are the early warning signs and developmental markers?

Early identification of Simpson-Golabi-Behmel syndrome often occurs in the neonatal period or early infancy. Physicians and parents should monitor for the following specific markers:

• Macrosomia: Birth weight and length often exceed the 97th percentile.


• Feeding difficulties: Often caused by macroglossia, which may impact latching or swallowing.


• Congenital heart defects: Present in approximately 25-50% of cases.


• Developmental delays: While cognitive function ranges from normal to intellectual disability, early speech and motor delays are common indicators.


• Abdominal wall defects: Including umbilical hernias or diastasis recti.

How does the severity of Simpson-Golabi-Behmel syndrome vary?

The clinical expression of Simpson-Golabi-Behmel syndrome is highly variable, even among family members with the same genetic mutation. Some individuals may exhibit only mild facial dysmorphism and normal intelligence, while others may face significant intellectual disability and severe structural organ issues. Because Simpson-Golabi-Behmel syndrome is X-linked, it primarily affects males, though female carriers may occasionally show milder clinical features. This variability makes long-term monitoring essential, as the impact on quality of life—particularly regarding mobility and communication—differs widely from person to person.

When should families seek immediate medical attention?

Because Simpson-Golabi-Behmel syndrome carries an increased risk of embryonal tumors—such as Wilms tumor, hepatoblastoma, and neuroblastoma—regular tumor surveillance is critical. Parents should seek immediate medical evaluation if they notice unexplained abdominal swelling, persistent pain, hematuria (blood in the urine), or sudden changes in growth patterns. Furthermore, any respiratory distress, especially in infants with macroglossia, requires urgent clinical assessment to ensure airway patency.

How do symptoms progress throughout the lifespan?

The progression of Simpson-Golabi-Behmel syndrome is not typically degenerative, but it is dynamic. During childhood, the primary focus is on growth monitoring and tumor surveillance. As the child matures, the focus often shifts toward managing skeletal issues, speech therapy, and educational support. While the overgrowth pattern may stabilize in adulthood, the need for specialized cardiac and renal monitoring often persists, necessitating a lifelong relationship with a genetics team and relevant specialists.

Next steps

• Consult a clinical geneticist to confirm the diagnosis via molecular testing (typically involving the GPC3 gene).


• Establish a multidisciplinary care team including a pediatric cardiologist, nephrologist, and oncologist.


• Join the DiseaseMaps.org community to connect with other families navigating the challenges of this rare condition.


• Schedule regular ultrasound screenings as recommended by your physician to mitigate tumor risks.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Simpson-Golabi-Behmel syndrome.


• Orphanet: Simpson-Golabi-Behmel syndrome (ORPHA:3300).


• OMIM (Online Mendelian Inheritance in Man): Simpson-Golabi-Behmel syndrome, Type 1 (#312870).